TY  - JOUR

T1  - AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers

JO  - npj Precision Oncology

UR  - https://doi.org/10.1038/s41698-023-00360-5

PY  - 2023/02/16

AU  - Abu-Khalaf MM

AU  - Alex Hodge K

AU  - Hatzis C

AU  - Baldelli E

AU  - El Gazzah E

AU  - Valdes F

AU  - Sikov WM

AU  - Mita MM

AU  - Denduluri N

AU  - Murphy R

AU  - Zelterman D et al

ED  - 

DO  - DOI: 10.1038/s41698-023-00360-5

PB  - Springer Science and Business Media LLC

VL  - 7

IS  - 1

Y2  - 2026/03/17

ER  -